Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Ability of Interleukin-33- and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune Responses.

Rivellese F, Suurmond J, Habets K, Dorjée AL, Ramamoorthi N, Townsend MJ, de Paulis A, Marone G, Huizinga TW, Pitzalis C, Toes RE.

Arthritis Rheumatol. 2015 Sep;67(9):2343-53. doi: 10.1002/art.39192.

2.

Interleukin-33 synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells.

Kashiwakura J, Yanagisawa M, Lee H, Okamura Y, Sasaki-Sakamoto T, Saito S, Tokuhashi Y, Ra C, Okayama Y.

Int Arch Allergy Immunol. 2013;161 Suppl 2:32-6. doi: 10.1159/000350424. Epub 2013 May 29.

PMID:
23711851
3.

Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.

Arthritis Rheum. 2004 May;50(5):1457-67.

4.

Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies.

Suurmond J, Rivellese F, Dorjée AL, Bakker AM, Rombouts YJ, Rispens T, Wolbink G, Zaldumbide A, Hoeben RC, Huizinga TW, Toes RE.

Ann Rheum Dis. 2015 Oct;74(10):1915-23. doi: 10.1136/annrheumdis-2014-205562. Epub 2014 May 12.

PMID:
24818634
5.
6.

Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fcγ receptor I and Fcγ receptor II.

Lee H, Kashiwakura J, Matsuda A, Watanabe Y, Sakamoto-Sasaki T, Matsumoto K, Hashimoto N, Saito S, Ohmori K, Nagaoka M, Tokuhashi Y, Ra C, Okayama Y.

Arthritis Rheum. 2013 Jan;65(1):109-19. doi: 10.1002/art.37741.

7.
8.

Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins.

Laurent L, Clavel C, Lemaire O, Anquetil F, Cornillet M, Zabraniecki L, Nogueira L, Fournié B, Serre G, Sebbag M.

Ann Rheum Dis. 2011 Jun;70(6):1052-9. doi: 10.1136/ard.2010.142091. Epub 2011 Mar 15.

PMID:
21406456
9.

Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.

Schuerwegh AJ, Ioan-Facsinay A, Dorjée AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2586-91. doi: 10.1073/pnas.0913054107. Epub 2010 Jan 25. Retraction in: Schuerwegh AJ, Ioan-Facsinay A, Dorjee AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20345.

10.
11.

The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.

Kragstrup TW, Greisen SR, Nielsen MA, Rhodes C, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Vorup-Jensen T, Robinson WH, Sokolove J, Deleuran B.

Arthritis Res Ther. 2016 Mar 11;18:61. doi: 10.1186/s13075-016-0964-7.

12.

Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.

Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, Willis CR, Bijlsma JW, Lafeber FP.

Arthritis Rheum. 2009 Sep;60(9):2595-605. doi: 10.1002/art.24754.

13.
14.

The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis.

Okamura Y, Mishima S, Kashiwakura JI, Sasaki-Sakamoto T, Toyoshima S, Kuroda K, Saito S, Tokuhashi Y, Okayama Y.

Allergol Int. 2017 Sep;66S:S9-S20. doi: 10.1016/j.alit.2017.03.002. Epub 2017 Mar 31.

15.

Interleukin-33 primes mast cells for activation by IgG immune complexes.

Kaieda S, Wang JX, Shnayder R, Fishgal N, Hei H, Lee RT, Stevens RL, Nigrovic PA.

PLoS One. 2012;7(10):e47252. doi: 10.1371/journal.pone.0047252. Epub 2012 Oct 11.

17.

Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.

Walter GJ, Evans HG, Menon B, Gullick NJ, Kirkham BW, Cope AP, Geissmann F, Taams LS.

Arthritis Rheum. 2013 Mar;65(3):627-38. doi: 10.1002/art.37832.

18.

Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.

Jüngel A, Distler JH, Kurowska-Stolarska M, Seemayer CA, Seibl R, Forster A, Michel BA, Gay RE, Emmrich F, Gay S, Distler O.

Arthritis Rheum. 2004 May;50(5):1468-76.

19.

Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients.

Rodenburg RJ, van Den Hoogen FH, Barrera P, van Venrooij WJ, van De Putte LB.

Ann Rheum Dis. 1999 Oct;58(10):648-52.

20.

Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation.

van Roon J, Wijngaarden S, Lafeber FP, Damen C, van de Winkel J, Bijlsma JW.

J Rheumatol. 2003 Apr;30(4):648-51.

PMID:
12672180

Supplemental Content

Support Center